BTK inhibitor 10
BTK inhibitor 10 is a potent and orally active Bruton kinase (BTK) inhibitor, extracted from patent WO2018145525, example 33. BTK inhibitor 10 has a potential for rheumatoid arthritis treatment[1].
Product Specifications
CAS Number
[2241732-30-7]
UNSPSC
12352005
Target
Btk
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/btk-inhibitor-10.html
Concentration
10mM
Purity
99.66
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
C=CC(NC1=CC=CC(OC2=C3C(NC(C4=CC=C(N5CCOCC5)C=C4)=C3)=NC=N2)=C1)=O
Molecular Formula
C25H23N5O3
Molecular Weight
441.48
References & Citations
[1]HuiJun Yin, et al. Pyrrolo-aromatic heterocyclic compound, preparation method therefor, and medical use thereof. Patent WO2018145525
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal TRAILR1/TNFRSF10A Antibody (HS101) [DyLight 594]](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
Mouse Monoclonal TRAILR1/TNFRSF10A Antibody (HS101) [DyLight 594]
